Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Literature DB >> 8082671

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

A R Wafelman¹, C A Hoefnagel, R A Maes, J H Beijnen.

Abstract

Since the introduction of radioiodinated metaiodobenzylguanidine in 1980, considerable research has been performed, both in the chemical field and in medical sciences. However, despite the wide use of radioiodinated metaiodobenzylguanidine, knowledge about its pharmacology is still limited. This paper reviews the biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry of radioiodinated metaiodobenzylguanidine. Iodine-131 metaiodobenzylguanidine therapy is in general well tolerated, but its effectiveness needs improvement. Also whole-body dosimetry as part of treatment planning needs to be improved. Future prospects on these items are included in this review.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1994 PMID： 8082671 DOI： 10.1007/bf00173043

Source DB: PubMed Journal: Eur J Nucl Med ISSN： 0340-6997

77 in total

1. Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG).

Authors: L A Smets; B Bout; J Wisse
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

2. Radionuclide therapy of neural crest tumors.

Authors: P A Voûte; C A Hoefnagel; J de Kraker; A E Evans; A Hayes; A Green
Journal: Med Pediatr Oncol Date: 1987

3. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.

Authors: G M Blake; V J Lewington; J S Fleming; M A Zivanovic; D M Ackery
Journal: Eur J Nucl Med Date: 1988

4. Salivary gland accumulation of meta-[131I]iodobenzylguanidine.

Authors: M Nakajo; B Shapiro; J C Sisson; D P Swanson; W H Beierwaltes
Journal: J Nucl Med Date: 1984-01 Impact factor: 10.057

5. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.

Authors: T Munkner
Journal: Semin Nucl Med Date: 1985-04 Impact factor: 4.446

6. Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patients.

Authors: G Ehninger; T Klingebiel; I Kumbier; U Schuler; U Feine; J Treuner; H D Waller
Journal: Cancer Res Date: 1987-11-15 Impact factor: 12.701

7. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.

Authors: A Iavarone; A Lasorella; T Servidei; R Riccardi; R Mastrangelo
Journal: Cancer Res Date: 1993-01-15 Impact factor: 12.701

Review 8. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors: C A Hoefnagel
Journal: Eur J Nucl Med Date: 1994-06

9. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.

Authors: S Jaques; M C Tobes; J C Sisson; J A Baker; D M Wieland
Journal: Mol Pharmacol Date: 1984-11 Impact factor: 4.436

10. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Authors: M N Gaze; R J Mairs; S M Boyack; T E Wheldon; A Barrett
Journal: Br J Cancer Date: 1992-12 Impact factor: 7.640

29 in total

1. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors: Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal: Eur J Nucl Med Mol Imaging Date: 2003-12 Impact factor: 9.236

2. 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors: Emilio Bombardieri; Francesco Giammarile; Cumali Aktolun; Richard P Baum; Angelika Bischof Delaloye; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Giovanna Pepe; Sven N Reske; Maria R Castellani; Arturo Chiti
Journal: Eur J Nucl Med Mol Imaging Date: 2010-12 Impact factor: 9.236

Review 3. Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Authors: B Shapiro
Journal: Ann Nucl Med Date: 1996-02 Impact factor: 2.668

Review 4. Targeted radiotherapy for neuroblastoma.

Authors: S Meller
Journal: Arch Dis Child Date: 1997-11 Impact factor: 3.791

5. Biodistribution and Dosimetry of ¹⁸F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.

Authors: Neeta Pandit-Taskar; Pat Zanzonico; Kevin D Staton; Jorge A Carrasquillo; Diane Reidy-Lagunes; Serge Lyashchenko; Eva Burnazi; Hanwen Zhang; Jason S Lewis; Ronald Blasberg; Steven M Larson; Wolfgang A Weber; Shakeel Modak
Journal: J Nucl Med Date: 2017-07-13 Impact factor: 10.057

Review 6. Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.

Authors: Arnold F Jacobson; Mark I Travin
Journal: J Nucl Cardiol Date: 2015-05-15 Impact factor: 5.952

7. False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma.

Authors: C Rottenburger; E Juettner; A C Harttrampf; M Hentschel; U Kontny; J Roessler
Journal: Br J Radiol Date: 2010-08 Impact factor: 3.039